JP Morgan Chase
OSTX icon

JP Morgan Chase’s OS Therapies Inc OSTX Stock Holding History

JP Morgan Chase’s Portfolio OSTX Stock Details OSTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$261 Buy
+162
New +$265 ﹤0.01% 7746
2025
Q4 		– Sell
-13
Closed -$25 – 7844
2025
Q3 		$25 Sell
13
-309
-96% -$612 ﹤0.01% 7274
2025
Q2 		$605 Buy
+322
New +$542 ﹤0.01% 6681

Other funds holding OSTX

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Howard Financial Services
Howard Financial Services Dallas, Texas $954M AUM 13.71% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $106B AUM 21.33% 1-Year Est. Return
Empowered Funds
Empowered Funds Havertown, Pennsylvania $21.7B AUM 41.23% 1-Year Est. Return
HRT Financial
HRT Financial New York $57.2B AUM 52.85% 1-Year Est. Return
Ingalls & Snyder LLC
Ingalls & Snyder LLC New York $3.91B AUM 60.54% 1-Year Est. Return

JP Morgan Chase's OSTX Position: Q3 2026 in Review

JP Morgan Chase opened a new position in OS Therapies Inc (OSTX) in Q3 2026: 162 shares worth $261. The stake represents ﹤0.01% of the portfolio and ranks #7746 among its holdings. This is a return to the name: JP Morgan Chase previously reported a position in OSTX as recently as Q3 2025.

JP Morgan Chase first reported a position in OSTX in Q2 2025 and has held it in 3 quarters since. The position peaked at $605 in Q2 2025. 25 funds tracked by Wall St. Rank hold OSTX as of Q3 2026.

  • JP Morgan Chase held 162 shares of OS Therapies Inc worth $261 as of Q3 2026.
  • OS Therapies Inc was a new JP Morgan Chase position in Q3 2026.
  • OS Therapies Inc made up ﹤0.01% of JP Morgan Chase's portfolio in Q3 2026, its #7746 holding.
  • JP Morgan Chase first reported a position in OS Therapies Inc in Q2 2025 and has held it in 3 quarters since.
  • JP Morgan Chase's OS Therapies Inc position peaked at $605 in Q2 2025.
  • 25 funds tracked by Wall St. Rank held OS Therapies Inc as of Q3 2026.

Based on JP Morgan Chase's 13F filing for Q3 2026, filed 12 Nov 2026.